Evidence map›Paper›PMID 41458487›Full record

ReviewFrontiers in medicine2025

Artificial intelligence for posterior capsule opacification.

Gurnoor Gill, David Taylor Gonzalez, Harshal Sanghvi, Mak Djulbegovic, Ayam Suleiman, Shailesh Gupta

Abstract readReview
In one paragraph

Review in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gurnoor GillCharles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, United States.
David Taylor GonzalezBroward Health North, Deerfield Beach, FL, United States.
Harshal SanghviCollege of Business, Florida Atlantic University, Boca Raton, FL, United States.
Mak DjulbegovicWills Eye Hospital, Philadelphia, PA, United States.
Ayam SuleimanAdvanced Research LLC, Deerfield Beach, FL, United States.
Shailesh GuptaBroward Health North, Deerfield Beach, FL, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Posterior capsule opacification (PCO) remains the most common long-term complication of cataract surgery, affecting up to one-fifth of patients within 5 years and often requiring neodymium: yttrium-aluminum-garnet (Nd:YAG) laser capsulotomy. Clinical decisions about if and when to intervene depend primarily on subjective assessments and carry non-trivial risks, including transient intraocular pressure spikes, cystoid macular edema, and rare retinal detachment. Recent advances in artificial intelligence (AI), spanning classical machine learning and deep convolutional neural networks, offer an objective, data-driven framework to (1) detect and grade PCO severity from imaging (retro-illumination photographs, OCT, Scheimpflug tomography), (2) stratify individual risk of clinically significant opacification and personalize follow-up, and (3) support timing and dosing of Nd:YAG capsulotomy. AI models have achieved expert-level performance (e.g., AUC up to 0.97 for binary detection of vision-threatening PCO, correlation r ≈ 0.83 for continuous severity scores, C-index ≈ 0.87 for capsulotomy risk nomograms), reducing observer bias and standardizing care. To address the "black-box" nature of complex models, mechanistic interpretability techniques, such as heatmaps and quantifiable feature extraction, are emerging to clarify decision logic and bolster clinician trust. Key challenges include assembling large, diverse, multi-center datasets (potentially via federated learning), prospective validation in real-world settings, regulatory approval, seamless integration into electronic health records and imaging workflows, and ensuring data privacy. Future directions emphasize true multimodal fusion of slit-lamp, OCT, and Scheimpflug tomography data, intraoperative feedback systems to minimize residual lens epithelial cells, patient-driven home monitoring via smartphone apps, and user-tunable AI thresholds to align with individual clinician and patient priorities. By combining transparent AI insights with surgical expertise, these tools can transform PCO management. They may optimize visual rehabilitation, minimize unnecessary procedures, and enhance safety in cataract postoperative care.

Indexed as

artificial intelligencecataract surgerydecision support systemsdeep learningposterior capsular opacification

Identifiers

PMID41458487
PMCPMC12741075

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.